"Heterozygote" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An individual having different alleles at one or more loci regarding a specific character.
| Descriptor ID |
D006579
|
| MeSH Number(s) |
G05.380.383
|
| Concept/Terms |
Genetic Carriers- Genetic Carriers
- Carrier, Genetic
- Genetic Carrier
- Carriers, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Heterozygote".
Below are MeSH descriptors whose meaning is more specific than "Heterozygote".
This graph shows the total number of publications written about "Heterozygote" by people in this website by year, and whether "Heterozygote" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 6 | 7 |
| 1997 | 0 | 3 | 3 |
| 1998 | 2 | 5 | 7 |
| 1999 | 2 | 3 | 5 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 8 | 8 |
| 2002 | 0 | 13 | 13 |
| 2003 | 1 | 9 | 10 |
| 2004 | 0 | 8 | 8 |
| 2005 | 1 | 6 | 7 |
| 2006 | 0 | 7 | 7 |
| 2007 | 0 | 7 | 7 |
| 2008 | 1 | 4 | 5 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 5 | 5 |
| 2011 | 7 | 10 | 17 |
| 2012 | 0 | 10 | 10 |
| 2013 | 1 | 13 | 14 |
| 2014 | 3 | 10 | 13 |
| 2015 | 2 | 14 | 16 |
| 2016 | 1 | 12 | 13 |
| 2017 | 0 | 12 | 12 |
| 2018 | 1 | 19 | 20 |
| 2019 | 1 | 5 | 6 |
| 2020 | 1 | 12 | 13 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 5 | 6 |
| 2025 | 1 | 5 | 6 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heterozygote" by people in Profiles.
-
Allele frequencies at recessive disease genes are mainly determined by pleiotropic effects in heterozygotes. Genetics. 2026 09 02; 234(1).
-
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial. Nat Med. 2026 Mar; 32(3):1052-1060.
-
Variant Calling in the Goldilocks Zone: How Reference Genome Choice and Read Mapping Stringency Impact Heterozygosity Estimates and Phylogenetic Analyses. Mol Ecol Resour. 2026 Jan; 26(1):e70079.
-
Skin Cancer Predisposition Genes, Full-Body Skin Examinations, Familial Disclosure, and Genetic Testing Among High-Risk Individuals. Int J Dermatol. 2026 Jul; 65(7):1431-1441.
-
A clinical and genotype-phenotype analysis of MACF1 variants. Am J Hum Genet. 2025 10 02; 112(10):2363-2380.
-
Diseases Common in Persons With Cystic Fibrosis Among CFTR Heterozygotes. JAMA Intern Med. 2025 08 01; 185(8):1014-1024.
-
Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations. J Thorac Oncol. 2025 11; 20(11):1683-1698.
-
Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer-Specific Polygenic Scores. Cancer Med. 2025 Jun; 14(11):e70990.
-
The Distribution and Dispersal of Large Haploblocks in a Superspecies. Mol Ecol. 2025 11; 34(21):e17731.
-
Causal interpretations of family GWAS in the presence of heterogeneous effects. Proc Natl Acad Sci U S A. 2024 09 17; 121(38):e2401379121.